Context While age-related changes in menstrual cycle length are well known, it is unclear
whether anti-Müllerian (AMH) or other ovarian reserve biomarkers have a direct association …

Objective Although menstrual cycle length is one of the main concerns of women and may
have important health consequences, little is known about its predictors. The aim of this …

Context Antimüllerian hormone (AMH) level is strongly associated with ovarian response in
assisted reproductive technology (ART) cycles but is a poor predictor of live birth. It is …

Context Anti-müllerian hormone (AMH) is produced by granulosa cells of small, growing
follicles in the ovary. Serum AMH levels strongly correlate with the number of growing …

Background AMH is widely used for assessing ovarian reserve, and it is particularly
convenient, because it is thought to have minimal variability throughout the menstrual cycle …

Objectives To evaluate the prognostic value of anti-Mullerian hormone (AMH) levels in
estimating the ovarian density of primordial and primary follicles, which can be assumed to …

Objective To determine whether levels of antimüllerian hormone (AMH) in serum vary during
the normal menstrual cycle, using the most recently developed immunoassay method …

Purpose Anti-Müllerian hormone (AMH) is a biomarker reflecting ovarian reserve. A low
AMH level before 39 years may be associated with a risk of menopause between 40 and 45 …

Context Evaluation of the infertile female requires an understanding of ovulation and
biomarkers of ovarian reserve. Antimüllerian hormone (AMH) correlates with growing …

Abstract Context: Anti-Müllerian hormone (AMH), a quantitative marker for ovarian reserve,
has been suggested to be independent of the classical endocrine fluctuations of the …